Presbyopia Market Size, Share, Competitive Analysis, Market Research and Forecast Report 2030

1. DelveInsight's "Presbyopia Market Insights, Epidemiology and Market Forecast 2030" report delivers an in-depth understanding of the Presbyopia , historical and forecasted epidemiology as well as the Presbyopia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. About the Disease Presbyopia is the normal loss of near focusing ability that occurs with age. Most people begin to notice the effects of presbyopia sometime after age 40. It is a result of a gradual decrease in accommodative amplitude, from about 15 diopters (D) to 1 D. This typically comes on between the ages of 40 and 60 as the lenses of the eyes naturally lose elasticity due to the aging process. Request for sample pages of our Market Report @https://www.delveinsight.com/sample- request/presbyopia-market Presbyopia can be classified by type which includes:  Incipient presbyopia  Functional presbyopia  Absolute presbyopia  Premature presbyopia  Nocturnal presbyopia Presbyopia Signs and Symptoms:  Prolonged close-up work, with tiring (eye strain) of the eyes  Delay in focusing at near or distance  Ocular discomfort  Headache  Asthenopia  Squinting

2.  Fatigue or drowsiness from near work  Increased working distance  Need for brighter light for reading  Diplopia The Presbyopia market report provides current treatment practices, emerging drugs, Presbyopia market share of the individual therapies, current and forecasted Presbyopia market Size from 2017 to 2030 segmented by seven major markets. The Report also covers current Presbyopia treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market. Download our free copy of sample pages: https://www.delveinsight.com/sample- request/presbyopia-market Presbyopia Epidemiology According to the American Optometric Association (AOA), Presbyopia is a vision condition in which the shape of the crystalline lens of the eye changes. These changes make it difficult to focus on close objects. Presbyopia usually becomes visible in the early to mid-40s, but the reduction in the vision of an individuals’ focus starts as early as childhood. The Presbyopia epidemiology division provide insights about historical and current Presbyopia patient pool and forecasted trend for every seven major countries. Key Findings  According to the research study of He et al. (2012), the prevalence rate of presbyopia was approximately 83% in the case of the United States.  In the case of the United States according to the research study of Holden et al. (2008) and Berdahl et al. (2020), the prevalence rate of presbyopia ranged from 83.0% to 88.9% for adults aged ≥45 years. Presbyopia Drug Chapters The dynamics of Presbyopia market is anticipated to change in the coming years due to the improvement in the diagnosis methodologies, raising awareness of the diseases, incremental healthcare spending across the world, and expected launch of emerging therapies during the forecast period 2021-2030. Key players such as Orasis Pharmaceuticals Ltd, Allergan, Novartis Pharmaceuticals, and others are developing therapies for presbyopia. AbbVie’s Allergan is developing, AGN-190584,an investigational optimized formulation of pilocarpine. It is a cholinergic muscarinic receptor agonist being investigated for treating symptoms associated with presbyopia as a topical, once-daily drop delivered by a proprietary vehicle. Drug chapter segment of the Presbyopia report encloses the detailed analysis of Presbyopia marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. It also helps to

3. understand the Presbyopia clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases. Presbyopia Market Outlook The first goal of presbyopia treatment is to compensate for the inability of eyes to focus on nearby objects. The treatment options include wearing corrective eyeglasses (spectacle lenses) or contact lenses, undergoing refractive surgery, or getting lens implants for presbyopia. Eyeglasses are the simplest and safest way to correct refractive errors. Contact Lenses work by becoming the first refractive surface for light rays entering the eye, causing more precise refraction or focus. In many cases, contact lenses provide clearer vision, a wider field of vision, and greater comfort. They are a safe and effective option if fitted and used properly. Refractive Surgery aims to change the shape of the cornea permanently. This change in eye shape restores the focusing power of the eye by allowing the light rays to focus precisely on the retina for improved vision. Numerous optical and surgical methods are available to decrease the symptoms of presbyopia. Optical methods reduce the symptoms when the optical device is in place. Surgical methods, directed either at the cornea or lens, alter the structure of the eyes to reduce presbyopic symptoms. The Presbyopia market outlook of the report helps to build the detailed comprehension of the historic, current, and forecasted Presbyopia markettrends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology. According to DelveInsight, Presbyopia market in 7MM is expected to change in the study period 2017-2030. Key Findings  The market size shall grow during the forecast period, i.e., 2018–2030, owing to the launch of novel therapies. The market size is expected to increase during the study period. Visit our repository of reports @https://www.delveinsight.com/report-store.php